Hepatic Hydatidosis
Dual albendazole treatment effective for surgical patients
Published in Medical Devices and Surgical Technology Week, July 31st, 2005
"Hepatic hydatidosis still remains as a serious problem in general surgery. Recurrence and/or secondary hydatidosis rates are up to 25% in the cases treated with surgery alone," surgeons in Turkey explained.
"Albendazole is the most commonly used drug in the medical treatment of echinococcosis," noted C. Polat and colleagues at Ondokuz Mayis University, who conducted a study to determine "the effect of albendazole using the intraoperative and perioperative periods as dual therapy."
"Fifty-two cases of hepatic hydatidosis were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Cardiac Pacemakers
Closed loop stimulation pacing effective in young patients - Femoral Shaft Fracture
External support device facilitates closed reduction - Otorhinolaryngology
Alaryngeal speech aid system developed - Peripheral Artery Disease
Distal protection devices improve safety of lower extremity treatment - ST Elevation Myocardial Infarction
NOGA useful in assessing post-PCI myocardial recovery - Acetabular Insufficiency
Novel pin placement technique improves hip reconstruction - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
